GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cargo Therapeutics Inc (NAS:CRGX) » Definitions » Price-to-Free-Cash-Flow

CRGX (Cargo Therapeutics) Price-to-Free-Cash-Flow : N/A (As of Apr. 13, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Cargo Therapeutics Price-to-Free-Cash-Flow?

As of today (2025-04-13), Cargo Therapeutics's share price is $4.26. Cargo Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-3.23. Hence, Cargo Therapeutics's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Cargo Therapeutics's Price-to-Free-Cash-Flow or its related term are showing as below:

CRGX's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 28.78
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Cargo Therapeutics's Free Cash Flow per Share for the three months ended in Dec. 2024 was $-0.74. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-3.23.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -126.70% per year.

During the past 4 years, Cargo Therapeutics's highest 3-Year average Free Cash Flow per Share Growth Rate was -126.70% per year. The lowest was -126.70% per year. And the median was -126.70% per year.


Cargo Therapeutics Price-to-Free-Cash-Flow Historical Data

The historical data trend for Cargo Therapeutics's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cargo Therapeutics Price-to-Free-Cash-Flow Chart

Cargo Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
- - - -

Cargo Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cargo Therapeutics's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Cargo Therapeutics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cargo Therapeutics's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cargo Therapeutics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cargo Therapeutics's Price-to-Free-Cash-Flow falls into.


;
;

Cargo Therapeutics Price-to-Free-Cash-Flow Calculation

Cargo Therapeutics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=4.26/-3.229
=N/A

Cargo Therapeutics's Share Price of today is $4.26.
Cargo Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.23.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Cargo Therapeutics  (NAS:CRGX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Cargo Therapeutics Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cargo Therapeutics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Cargo Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.